Hope S. Rugo, MD, on Immunotherapy Combinations for Breast Cancer

Posted: Wednesday, January 2, 2019

Hope S. Rugo, MD, of the University of California, San Francisco, discusses new immunotherapy drug combinations, predictive factors, and the immune microenvironment, and how they relate to the NCCN Guidelines.